Skip to main content

Radiopharm Theranostics Health Care
Biotech Cancer Healthcare Medical

$0.105 -0.010 (-8.70%)

High

$0.12

Low

$0.10

Trades

57

Turnover

$206,557

Volume

1,951,148
30 June 2023 at 4:10pm
If you were already registered, log in here.

[ARTICLE] Biotech CEOs hit the streets amid sector sell-off

...

MediaBot

A news article has been posted about Radiopharm Theranostics on the AFR. The article was published around , on 17 March 2022 at 5:33am.

Overseas CEOs from Chimeric Therapeutics, BCAL Diagnostics and Radiopharm Theranostics are fronting local investors, hoping to shore up support amid the sell-off.

Read Article

RAD was $0.27 at the close of trade on 16 March 2022

Recent Articles about ASX:RAD
31-Dec Radiopharm Theranostics Limited (RADX)

finance.yahoo.com
31-Dec Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday

benzinga.com
31-Dec Radiopharm Theranostics: Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

finanznachrichten.de
31-Dec Radiopharm enters co-development partnership with Lantheus

markets.businessinsider.com
30-Dec Radiopharm Theranostics (ASX:RAD) Partners with Lantheus to Advance Radiopharmaceutical Development

kalkinemedia.com
30-Dec Radiopharm Theranostics partners with Lantheus to advance radiopharmaceutical development

grafa.com
28-Dec Radiopharm Theranostics Ltd ADR

au.investing.com
27-Dec Radiopharm Theranostics Ltd ADR

in.investing.com
27-Dec Radiopharm Theranostics Ltd ADR

in.investing.com
25-Dec Radiopharm Theranostics gets HREC approval to start study of 177Lu-labelled RAD 202 for treatment of HER2-expressing solid tumours

pharmabiz.com
Tracked

Find all articles about Radiopharm Theranostics, including others on the AFR, on the media page.

If you were already registered, log in here.

If you were already registered, log in here.

If you were already registered, log in here.